Supernus Pharmaceuticals Inc. (SUPN)
NASDAQ · Healthcare
Supernus Pharmaceuticals Inc. EPS 2010–2025
Supernus Pharmaceuticals Inc. annual/quarterly eps history and growth rate from 2012 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Supernus Pharmaceuticals Inc. eps for the quarter ending March 31, 2026 was $0.04, a 80.95% decrease year-over-year.
- Supernus Pharmaceuticals Inc. annual eps for 2025 was $0.68, a 151.52% decrease from 2024.
- Supernus Pharmaceuticals Inc. annual eps for 2024 was $1.32, a 6500.00% increase from 2023.
- Supernus Pharmaceuticals Inc. annual eps for 2023 was $0.02, a 98.08% decrease from 2022.
- Supernus Pharmaceuticals Inc. annual eps for 2022 was $1.04.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Supernus Pharmaceuticals Inc. EPS — FAQ
Supernus Pharmaceuticals Inc. (SUPN) eps over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
What is Supernus Pharmaceuticals Inc.'s eps?
Supernus Pharmaceuticals Inc. (SUPN) reported eps of $-0.68 for fiscal 2025.
Where can I see SUPN's eps history?
The chart and table above show Supernus Pharmaceuticals Inc.'s eps by year and by quarter, including the growth rate.